ArticleEMBO molecular medicine2016

Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.

Alexander Scholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.